Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer

• Publication date

  2010-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.25043PMID 20564402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guideline for management of the clinical T1 renal mass.

  2009cited by this paper
• Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

  2009cited by this paper
• Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

  2009cited by this paper
• Randomized trial of p53 targeted adjuvant therapy for patients (pts) with organ- confined node-negative urothelial bladder cancer (UBC).

  2009cited by this paper
• THE ROLE OF LYMPH‐NODE DISSECTION IN THE TREATMENT OF UPPER URINARY TRACT CANCER: A MULTI‐INSTITUTIONAL STUDY

  2008cited by this paper
• A sequential treatment approach to muscle-invasive urothelial cancer: A phase II Southwest Oncology Group Trial (S0219) of neoadjuvant paclitaxel, carboplatin, and gemcitabine (PCG)

  2008cited by this paper
• Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.

  2008influential reference
• Cancer Statistics, 2008

  2008cited by this paper
• Advanced bladder cancer: Status of first‐line chemotherapy and the search for active agents in the second‐line setting

  2008cited by this paper
• The role of lymph‐node dissection in the treatment of upper urinary tract cancer: a multi‐institutional study

  2008cited by this paper
• Adjuvant chemotherapy (AC) with cisplatin + gemcitabine (CG) versus chemotherapy (CT) at relapse (CR) in patients (pts) with muscle-invasive bladder cancer (MIBC) submitted to radical cystectomy (RC). An Italian multicenter randomised phase III trial

  2008cited by this paper
• Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.

  2007cited by this paper
• Defining optimal therapy for muscle invasive bladder cancer.

  2007cited by this paper
• Factors predicting renal functional outcome after partial nephrectomy.

  2007cited by this paper
• Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

  2006cited by this paper
• Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

  2005cited by this paper
• Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

  2005cited by this paper
• Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

  2005cited by this paper
• Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

  2005cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium

  2004cited by this paper
• Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

  2003influential reference
• Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

  2003cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

  1998cited by this paper
• Carboplatin‐based versus cisplatin‐based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma

  1997cited by this paper
• Comparison between a cisplatin‐containing regimen and a carboplatin‐containing regimen for recurrent or metastatic bladder cancer patients: A randomized phase II study

  1996cited by this paper
• A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.

  1996cited by this paper
• Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study.

  1992cited by this paper
• The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Ascertainment of vital status through the National Death Index and the Social Security Administration.

  1985cited by this paper

• Does perioperative chemotherapy affect renal function after radical nephroureterectomy for upper tract urothelial carcinoma?

  2026influential citation
• Is More Better? Evaluating Neoadjuvant Chemotherapy Cycles Before Surgery for High-Risk Upper Tract Urothelial Carcinoma.

  2026cites this paper
• Comparison of the oncological and functional outcomes among patients with high‐risk upper tract urothelial cancer undergoing segmental ureterectomy based on tumour location

  2025cites this paper
• A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial Carcinoma

  2025cites this paper
• Urothelial carcinoma: Perioperative considerations from top to bottom

  2025cites this paper
• The Influence of Chronic Kidney Disease on the Management of Upper Urinary Tract Cancer Following Radical Nephroureterectomy: A Nationwide Multi-Institutional Study.

  2025cites this paper
• Long-term outcome of radiation therapy for locoregional recurrence of upper tract urothelial carcinoma after nephroureterectomy

  2025cites this paper
• Renal parenchymal volume analysis: Clinical and research applications

  2025cites this paper
• The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study

  2025cites this paper
• Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy

  2024cites this paper
• Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey.

  2024cites this paper
• Kidney-Sparing Surgery for Upper Tract Urothelial Carcinoma—Modalities, Outcomes, and Limitations

  2024influential citation
• The Long-Term Functional and Oncologic Outcomes of Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma

  2024cites this paper
• Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of Experience

  2024cites this paper
• Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial Carcinoma.

  2024cites this paper
• Blood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma

  2024cites this paper
• Exploring Radiotherapy as a Promising Alternative for Managing Advanced Upper Tract Urothelial Carcinoma: Rescuing Chemotherapy-Intolerant Patients.

  2024cites this paper
• Prognostic factors for overall survival in clinical node‐positive patients with upper tract urothelial carcinoma

  2024cites this paper
• Comparison of European and American Guidelines for Upper Tract Urothelial Carcinoma: How Are They different?

  2024cites this paper
• Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry

  2024cites this paper
• The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes

  2024influential citation
• Measurement of tissue optical properties in the 400 to 700 nm range to assess light penetration depths for laser treatment of upper tract urothelial carcinomas

  2024cites this paper
• Chronic renal impairment predicts oncological outcomes in UTUC patients undergoing RNU

  2024cites this paper
• Risk factors of renal function deterioration after radical nephroureterectomy for upper tract urothelial carcinoma

  2024cites this paper
• Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.

  2024cites this paper
• Kidney sparing surgery versus radical nephroureterectomy in upper tract urothelial carcinoma: a meta-analysis and systematic review

  2024cites this paper
• Urothelial cancer: state of art in Ukraine and improvement pathways

  2024cites this paper
• Upper Tract Urothelial Cancer: Guideline of Guidelines

  2024cites this paper
• Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective study.

  2024cites this paper
• Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma

  2023cites this paper
• Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods—what’s around the corner?

  2023cites this paper
• Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association

  2023cites this paper
• Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study

  2023cites this paper
• Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma

  2023cites this paper
• Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario

  2023cites this paper
• Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study

  2023cites this paper
• Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

  2023cites this paper
• CT- und MRT-Bildgebung der Niere und potenzieller Lokalisationen von Metastasen

  2023cites this paper
• Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study

  2023cites this paper
• [Preoperative chemotherapy for patients with upper tract urothelial carcinoma: Impact on renal function].

  2023cites this paper
• The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.

  2022cites this paper
• Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper-Tract Urothelial Carcinoma of the Ureter Compared to Radical Nephroureterectomy?

  2022cites this paper
• A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: Study protocol of the FLUAM trial

  2022cites this paper
• Free Ferrous Protoporphyrin and Reactive Oxygen Species Status of Voided Urine Predicts Higher Stage in Urothelial Carcinoma

  2022cites this paper
• Clinical Implication of Preoperative Renal Function on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy

  2022cites this paper
• MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?

  2022cites this paper
• Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee

  2022cites this paper
• Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?

  2022cites this paper
• Tumeur de la voie excrétrice supérieure

  2022cites this paper
• The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy

  2022cites this paper
• Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context

  2022cites this paper
• Neoadjuvant Chemotherapy before Nephroureterectomy in High-Risk Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study.

  2021cites this paper
• MP48-06 ONCOLOGICAL OUTCOMES OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED UPPER TRACT UROTHELIAL CARCINOMA: A MULTICENTER RETROSPECTIVE STUDY

  2021cites this paper
• Comparing Oncological Outcomes and Surgical Complications of Hand-Assisted, Laparoscopic and Robotic Nephroureterectomy for Upper Tract Urothelial Carcinoma

  2021cites this paper
• National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.

  2021cites this paper
• Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma

  2021cites this paper
• Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.

  2021cites this paper
• A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group).

  2021cites this paper
• Diagnostic ureteroscopy for upper tract urothelial carcinoma: friend or foe?

  2021influential citation
• Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions

  2021cites this paper
• European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.

  2020cites this paper
• Prognostic impact of preoperative renal function in patients treated with radical cystectomy: a multi-institutional retrospective study

  2020cites this paper
• Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma

  2020cites this paper
• Impact of nephron sparing surgery on survival in upper urinary tract urothelial carcinoma patients stratified by tumor characteristics

  2020cites this paper
• Perioperative Chemotherapy on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma Undergoing Nephroureterectomy: A Population-Based Study

  2020cites this paper
• Impact of neoadjuvant chemotherapy on survival prognosis and pathological downstaging in patients presenting with high-risk upper tract urothelial carcinoma

  2020cites this paper
• Controversies in management of the bladder cuff at nephroureterectomy

  2020cites this paper
• Perioperative chemotherapy in the management of high risk upper tract urothelial cancers

  2020cites this paper
• Perioperative therapies for urological cancers.

  2020cites this paper
• Long term outcomes of ureteroscopic management of upper tract urothelial carcinoma.

  2020cites this paper
• Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model.

  2020cites this paper
• Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.

  2020cites this paper
• The impact of hospital volume on short-term and long-term outcomes for patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.

  2020cites this paper
• Survival Outcomes in Neoadjuvant Chemotherapy for High Grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis.

  2020cites this paper
• Postoperative Nomogram for Predicting Relapse-Free Survival after Radical Nephroureterectomy Combined with Chemotherapy in Patients with Upper Tract Urothelial Carcinoma

  2020cites this paper
• Neoadjuvant chemotherapy for upper tract urothelial carcinoma

  2020cites this paper
• Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study.

  2020cites this paper
• Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

  2020cites this paper
• Systemtherapie des metastasierten Tumors des oberen Harntraktes

  2019cites this paper
• 5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase

  2019cites this paper
• Diagnosis and Prognostic Factors of UTUC

  2019cites this paper
• Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study

  2019cites this paper
• Keep the corners; impact of chemotherapy on renal function

  2019cites this paper
• Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.

  2019cites this paper
• Segmental resection of distal ureter with termino‐terminal ureteric anastomosis vs bladder cuff removal and ureteric re‐implantation for upper tract urothelial carcinoma: results of a multicentre study

  2019cites this paper
• N-Heterocyclic Carbene-Platinum Complexes Featuring an Anthracenyl Moiety: Anti-Cancer Activity and DNA Interaction

  2019cites this paper
• EAU Guidelines pro diagnostiku a léčbu uroteliálního karcinomu

  2019cites this paper
• Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis

  2019cites this paper
• Consultation on UTUC, Stockholm 2018: aspects of treatment

  2019cites this paper
• Das fortgeschrittene Urothelkarzinom des oberen Harntrakts

  2019cites this paper
• Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma.

  2019cites this paper
• Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study.

  2019cites this paper
• Impact of the preoperative prognostic nutritional index on survival outcomes in upper tract urothelial carcinomas

  2019cites this paper
• Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway

  2019cites this paper
• Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis

  2019cites this paper
• Urothelial cancer: Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum

  2018cites this paper
• Systemic Chemotherapy for Upper Tract Urothelial Cancer

  2018cites this paper
• Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma

  2018cites this paper
• Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: A national cancer database study.

  2018cites this paper